Hepatoblastoma Rhabdomyosarcoma clinical trials

Explore recruiting hepatoblastoma rhabdomyosarcoma clinical trials.

Recruiting hepatoblastoma rhabdomyosarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatoblastoma Rhabdomyosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

Sweden, France, Germany, Spain, Belgium, Czechia +6 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Hepatoblastoma Rhabdomyosarcoma trials by city

Hepatoblastoma Rhabdomyosarcoma clinical trials

Recruiting hepatoblastoma rhabdomyosarcoma studies right now

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Also recruiting in Europe

LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

Hepatoblastoma Rhabdomyosarcoma trials by city

Other conditions